Iradimed Corporation (NASDAQ:IRMD) Position Increased by Aristides Capital LLC

Aristides Capital LLC lifted its position in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 62.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 29,925 shares of the medical equipment provider's stock after buying an additional 11,452 shares during the period. Aristides Capital LLC owned approximately 0.24% of Iradimed worth $1,646,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Shaker Investments LLC OH raised its holdings in Iradimed by 0.8% in the fourth quarter. Shaker Investments LLC OH now owns 29,894 shares of the medical equipment provider's stock valued at $1,644,000 after buying an additional 233 shares during the period. Bridge City Capital LLC increased its position in shares of Iradimed by 0.8% in the fourth quarter. Bridge City Capital LLC now owns 61,899 shares of the medical equipment provider's stock worth $3,404,000 after acquiring an additional 462 shares in the last quarter. Jacobs Levy Equity Management Inc. raised its stake in shares of Iradimed by 1.9% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 24,779 shares of the medical equipment provider's stock valued at $1,246,000 after acquiring an additional 472 shares during the period. Huntington National Bank lifted its holdings in shares of Iradimed by 34.0% during the 4th quarter. Huntington National Bank now owns 1,993 shares of the medical equipment provider's stock valued at $110,000 after acquiring an additional 506 shares in the last quarter. Finally, US Bancorp DE boosted its position in Iradimed by 476.6% during the 4th quarter. US Bancorp DE now owns 617 shares of the medical equipment provider's stock worth $34,000 after purchasing an additional 510 shares during the period. 92.34% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

Several research firms have commented on IRMD. StockNews.com lowered Iradimed from a "strong-buy" rating to a "buy" rating in a research report on Thursday, March 13th. Roth Mkm reiterated a "buy" rating and issued a $72.00 price objective (up previously from $60.00) on shares of Iradimed in a report on Friday, February 14th.

Iradimed Stock Up 2.8 %

Shares of IRMD traded up $1.42 during trading on Friday, reaching $51.52. The company's stock had a trading volume of 5,781 shares, compared to its average volume of 44,411. The company has a market cap of $655.06 million, a price-to-earnings ratio of 34.14 and a beta of 0.82. The company has a fifty day moving average of $54.12 and a two-hundred day moving average of $54.04. Iradimed Corporation has a twelve month low of $40.18 and a twelve month high of $63.29.

Iradimed (NASDAQ:IRMD - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The medical equipment provider reported $0.40 EPS for the quarter, missing analysts' consensus estimates of $0.45 by ($0.05). The company had revenue of $19.39 million for the quarter, compared to the consensus estimate of $19.09 million. Iradimed had a net margin of 26.26% and a return on equity of 24.12%. As a group, equities analysts forecast that Iradimed Corporation will post 1.66 EPS for the current fiscal year.

Iradimed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th were paid a dividend of $0.17 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.68 annualized dividend and a yield of 1.32%. This is a boost from Iradimed's previous quarterly dividend of $0.15. Iradimed's dividend payout ratio is presently 45.33%.

Iradimed Company Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.